Determination and pharmacokinetic study of isothiouronium-modified pyrimidine-substituted curcumin analog (1G), a novel antitumor agent, in rat plasma by liquid chromatography–tandem mass spectrometry

References

• Yao M, Yang L, Wang J, et al. Neurological recovery and antioxidant effects of curcumin for spinal cord injury in the rat: a network meta-analysis and systematic review. J Neurotrauma. 2015;32:381–391.
   PubMed Web of Science ®Google Scholar
• Alves TF, Chaud MV, Grotto D, et al. Association of silver nanoparticles and curcumin solid dispersion: antimicrobial and antioxidant properties. AAPS PharmSciTech. 2018;19:225–231.
   PubMed Web of Science ®Google Scholar
• He Y, Yue Y, Zheng X, et al. Curcumin, inflammation, and chronic diseases: how are they linked? Molecules. 2015;20:9183–9213.
   PubMed Web of Science ®Google Scholar
• Ma F, Liu F, Ding L, et al. Anti-inflammatory effects of curcumin are associated with down regulating microRNA-155 in LPS-treated macrophages and mice. Pharm Biol. 2017;55:1263–1273.
   PubMed Web of Science ®Google Scholar
• Ghosh A, Banerjee T, Bhandary S, et al. Formulation of nanotized curcumin and demonstration of its antimalarial efficacy. Int J Nanomedicine. 2014;9:5373–5387.
   PubMed Web of Science ®Google Scholar
• Marti Coma-Cros E, Biosca A, Lantero E, et al. Antimalarial activity of orally administered curcumin incorporated in Eudragit((R))-containing liposomes. Int J Mol Sci. 2018;19:E1361.
   PubMed Web of Science ®Google Scholar
• Marslin G, Sarmento BF, Franklin G, et al. Curcumin encapsulated into methoxy poly(ethylene glycol) poly(epsilon-caprolactone) nanoparticles increases cellular uptake and neuroprotective effect in glioma cells. Planta Med. 2017;83:434–444.
   PubMed Web of Science ®Google Scholar
• Djiokeng Paka G, Doggui S, Zaghmi A, et al. Neuronal uptake and neuroprotective properties of curcumin-loaded nanoparticles on SK-N-SH cell line: role of poly(lactide-co-glycolide) polymeric matrix composition. Mol Pharmaceutics. 2016;13:391–403.
   PubMed Web of Science ®Google Scholar
• Sun D, Zhou JK, Zhao L, et al. Novel curcumin liposome modified with hyaluronan targeting CD44 plays an anti-leukemic role in acute myeloid leukemia in vitro and in vivo. ACS Appl Mater Interfaces. 2017;9:16857–16868.
   PubMed Web of Science ®Google Scholar
• Zheng BZ, Liu TD, Chen G, et al. The effect of curcumin on cell adhesion of human esophageal cancer cell. Eur Rev Med Pharmacol Sci. 2018;22:551–560.
   PubMed Web of Science ®Google Scholar
• Huang F, Yao Y, Wu J, et al. Curcumin inhibits gastric cancer-derived mesenchymal stem cells mediated angiogenesis by regulating NF-kappaB/VEGF signaling. Am J Transl Res. 2017;9:5538–5547.
   PubMed Web of Science ®Google Scholar
• Marquardt JU, Gomez-Quiroz L, Arreguin Camacho LO, et al . Curcumin effectively inhibits oncogenic NF-κB signaling and restrains stemness features in liver cancer. J Hepatol. 2015;63:661–669.
   PubMed Web of Science ®Google Scholar
• Zhan JW, Jiao DM, Wang Y, et al. Integrated microRNA and gene expression profiling reveals the crucial miRNAs in curcumin anti-lung cancer cell invasion. Thorac Cancer. 2017;8:461–470.
   PubMed Web of Science ®Google Scholar
• Zaman MS, Chauhan N, Yallapu MM, et al. Curcumin nanoformulation for cervical cancer treatment. Sci Rep. 2016;6:20051
   PubMed Web of Science ®Google Scholar
• Anand P, Kunnumakkara AB, Newman RA, et al. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007;4:807–818.
   PubMed Web of Science ®Google Scholar
• Carolina Alves R, Perosa Fernandes R, Fonseca-Santos B, et al. A critical review of the properties and analytical methods for the determination of curcumin in biological and pharmaceutical matrices. Crit Rev Anal Chem. 2018.
   PubMed Web of Science ®Google Scholar
• Peng S, Li Z, Zou L, et al. Improving curcumin solubility and bioavailability by encapsulation in saponin-coated curcumin nanoparticles prepared using a simple pH-driven loading method. Food Funct. 2018;9:1829–1839.
   PubMed Web of Science ®Google Scholar
• Liang H, Friedman JM, Nacharaju P. Fabrication of biodegradable PEG-PLA nanospheres for solubility, stabilization, and delivery of curcumin. Artif Cells Nanomed Biotechnol. 2017;45:297–304.
   PubMed Web of Science ®Google Scholar
• Kumar S, Kesharwani SS, Mathur H, et al. Molecular complexation of curcumin with pH sensitive cationic copolymer enhances the aqueous solubility, stability and bioavailability of curcumin. Eur J Pharm Sci. 2016;82:86–96.
   PubMed Web of Science ®Google Scholar
• Chaharband F, Kamalinia G, Atyabi F, et al. Formulation and in vitro evaluation of curcumin-lactoferrin conjugated nanostructures for cancerous cells. Artif Cells Nanomed Biotechnol. 2018;46:626–636.
   PubMed Web of Science ®Google Scholar
• Qiu P, Xu L, Gao L, et al. Exploring pyrimidine-substituted curcumin analogues: design, synthesis and effects on EGFR signaling. Bioorg Med Chem. 2013;21:5012–5020.
   PubMed Web of Science ®Google Scholar
• Shen T, Jiang T, Long M, et al. A curcumin derivative that inhibits vinyl carbamate-induced lung carcinogenesis via activation of the Nrf2 protective response. Antioxid Redox Signal. 2015;23:651–664.
   PubMed Web of Science ®Google Scholar
• Tong S, Zhang M, Wang S, et al. Isothiouronium modification empowers pyrimidine-substituted curcumin analogs potent cytotoxicity and Golgi localization. Eur J Med Chem. 2016;123:849–857.
   PubMed Web of Science ®Google Scholar
• Garralda E, Dienstmann R, Tabernero J. Pharmacokinetic/pharmacodynamic modeling for drug development in oncology. Am Soc Clin Oncol Educ Book. 2017;37:210–215.
   PubMedGoogle Scholar
• Jiang J, Zhang Y, Zhang Q, et al. Development and validation of an LC-MS/MS method for the determination of SB-505124 in rat plasma: application to pharmacokinetic study. J Pharm Biomed Anal. 2016;117:205–209.
   PubMed Web of Science ®Google Scholar
• Baselga J, Mita AC, Schoffski P, et al. Using pharmacokinetic and pharmacodynamic data in early decision making regarding drug development: a phase I clinical trial evaluating tyrosine kinase inhibitor, AEE788. Clin Cancer Res. 2012;18:6364–6372.
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration CfDEaR. Guidance for Industry: Bioanalytical Method Validation; 2018. Available from: https://www.fda.gov/ucm/groups/fdagov-public/@fdagov-drugs-gen/documents/document/ucm070107.pdf.
   Google Scholar
• Davies B, Morris T. Physiological parameters in laboratory animals and humans. Pharm Res. 1993;10:1093–1095.
   PubMed Web of Science ®Google Scholar